Clinical Trial Update: Ofatumumab (Humax-CD20) With CHOP (Cyclophosphamide,Doxorubicin, Vincristine, Predisolone) in Follicular Lymphoma (FL) Patients [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating ofatumumab in combination with CHOP chemotherapy in follicular lymphoma completed; results were posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Follicular Lymphoma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Doxorubicin (doxorubicin)
• Ofatumumab (ofatumumab)
• PREDNISONE (Prednisone)
• Vincristine (vincristine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Lymphoma, Follicular | Phase 2 | Status: COMPLETED | Results posted: 2011-08-26